You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
| Title |
Dapagliflozin add-on to metformin in type 2 diabetes inadequately controlled with metformin: a randomized, double-blind, placebo-controlled 102-week trial
|
|---|---|
| Published in |
BMC Medicine, February 2013
|
| DOI | 10.1186/1741-7015-11-43 |
| Pubmed ID | |
| Authors |
Clifford J Bailey, Jorge L Gross, Delphine Hennicken, Nayyar Iqbal, Traci A Mansfield, James F List |
| Abstract |
Management of type 2 diabetes with metformin often does not provide adequate glycemic control, thereby necessitating add-on treatment. In a 24-week clinical trial, dapagliflozin, an investigational sodium glucose cotransporter 2 inhibitor, improved glycemic control in patients inadequately controlled with metformin. The present study is an extension that was undertaken to evaluate dapagliflozin as long-term therapy in this population. |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| United Kingdom | 2 | 67% |
| Unknown | 1 | 33% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 67% |
| Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 251 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Brazil | 2 | <1% |
| United Kingdom | 2 | <1% |
| Netherlands | 1 | <1% |
| South Africa | 1 | <1% |
| Denmark | 1 | <1% |
| Spain | 1 | <1% |
| Japan | 1 | <1% |
| Croatia | 1 | <1% |
| Unknown | 241 | 96% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Other | 30 | 12% |
| Student > Master | 26 | 10% |
| Student > Bachelor | 26 | 10% |
| Researcher | 24 | 10% |
| Student > Ph. D. Student | 21 | 8% |
| Other | 51 | 20% |
| Unknown | 73 | 29% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 103 | 41% |
| Pharmacology, Toxicology and Pharmaceutical Science | 20 | 8% |
| Agricultural and Biological Sciences | 14 | 6% |
| Biochemistry, Genetics and Molecular Biology | 11 | 4% |
| Nursing and Health Professions | 6 | 2% |
| Other | 16 | 6% |
| Unknown | 81 | 32% |
Attention Score in Context
This research output has an Altmetric Attention Score of 22. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 15 June 2022.
All research outputs
#1,491,100
of 22,919,505 outputs
Outputs from BMC Medicine
#1,042
of 3,445 outputs
Outputs of similar age
#12,189
of 193,401 outputs
Outputs of similar age from BMC Medicine
#36
of 96 outputs
Altmetric has tracked 22,919,505 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 93rd percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,445 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 43.6. This one has gotten more attention than average, scoring higher than 69% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 193,401 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 93% of its contemporaries.
We're also able to compare this research output to 96 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 63% of its contemporaries.